UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases

Current cancer drug targets, 2010-11, Vol.10 (7), p.649-659

2010

Volltextzugriff (PDF)

A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer’s Disease

The Journal Of Prevention of Alzheimer's Disease, 2022, Vol.9 (2), p.247-254

2022

Volltextzugriff (PDF)

An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6

Osteoporosis international, 2014-02, Vol.25 (2), p.681-692

2014

Volltextzugriff (PDF)

c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation

Bone (New York, N.Y.), 2012-05, Vol.50, p.S71-S71

2012

Volltextzugriff (PDF)

Chondroadherin prevents bone loss and inhibits tumor growth in animal models of osteoporosis and cancer-induced bone disease

Bone (New York, N.Y.), 2012-12, Vol.51 (6), p.S13-S13

2012

Volltextzugriff (PDF)

Lipocalin 2 is a novel mechanoresponding gene involved in osteoblast differentiation and osteoblast–osteoclast cross-talk

Bone (New York, N.Y.), 2009-06, Vol.44, p.S220-S220

2009

Volltextzugriff (PDF)

Pre-clinical employment of the heparin binding domain of PRELP in the treatment of bone loss diseases

Bone (New York, N.Y.), 2012-05, Vol.50, p.S61-S61

2012

Volltextzugriff (PDF)

Lipocalin2 is a new regulator of osteoblast functions in response to mechanical forces

Bone (New York, N.Y.), 2012-05, Vol.50, p.S42-S42

2012

Volltextzugriff (PDF)

978 Effects of 1D11 an Antibody Against Transforming Growth Factor Beta (TGF-b) on Incidence and Local Growth of Prostate Cancer Bone Metastases

European journal of cancer (1990), 2012-07, Vol.48, p.S236-S236

2012

Volltextzugriff (PDF)

976 Effects of Dual PI3K and mTOR Inhibition on Incidence and Local Growth of Prostate Cancer Bone Metastases

European journal of cancer (1990), 2012-07, Vol.48, p.S235-S235

2012

Volltextzugriff (PDF)

A new therapeutic approach to prevent oestrogen-withdrawal induced bone loss

Bone (New York, N.Y.), 2011-05, Vol.48, p.S226-S226

2011

Volltextzugriff (PDF)

Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans

Journal of bone and mineral research, 2011-08, Vol.26 (8), p.1891-1903

2011

Volltextzugriff (PDF)

The integrin binding domain of chondroadherin is a potential new target for drug development to treat bone metastases, affecting the players of the vicious cycle

Bone (New York, N.Y.), 2010-06, Vol.47, p.S37-S37

2010

Volltextzugriff (PDF)

Systemic and local determinants contribute to the bone phenotype in duchenne muscular dystrophy

Bone (New York, N.Y.), 2011-05, Vol.48, p.S246-S246

2011

Volltextzugriff (PDF)

Up-regulation of a set of genes in breast cancer bone metastases discloses predisposition to generate metastases also in visceral organs

Bone (New York, N.Y.), 2011-05, Vol.48, p.S74-S74

2011

Volltextzugriff (PDF)

The heparin binding domain of the bone protein proline/arginine-rich end leucine-rich repeat protein (PRELP) counteracts bone loss in ovariectomised (OVX) mice

Bone (New York, N.Y.), 2010-06, Vol.47, p.S142-S143

2010

Volltextzugriff (PDF)

Role of RAMP2 and BSP2 in the c-Src-regulated osteomimicry of breast cancer bone metastasis

Bone (New York, N.Y.), 2009-06, Vol.44, p.S273-S273

2009

Volltextzugriff (PDF)

Mechanisms underlying low bone density in muscular dystrophy

Bone (New York, N.Y.), 2009-07, Vol.45, p.S60-S61

2009

Volltextzugriff (PDF)

Mechanisms inducing low bone density in Duchenne Muscular Dystrophy

Bone (New York, N.Y.), 2009-06, Vol.44, p.S237-S238

2009

Volltextzugriff (PDF)

Proline/arginine‐rich end leucine‐rich repeat protein N‐terminus is a novel osteoclast antagonist that counteracts bone loss

Journal of bone and mineral research, 2013-09, Vol.28 (9), p.1912-1924

2013

Volltextzugriff (PDF)

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs

Journal of bone and mineral research, 2012-11, Vol.27 (11), p.2387-2398

2012

Volltextzugriff (PDF)

368 The molecular switch NHERF1 induces tumour phenotypic changes associated with distinct metastatic organotropism in breast cancer via its PDZ domains

European journal of cancer supplements, 2010, Vol.8 (5), p.94-94

2010

Volltextzugriff (PDF)

β‐Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice

Journal of bone and mineral research, 2009-05, Vol.24 (5), p.775-784

2009

Volltextzugriff (PDF)

NHERF1 programs invasive and metastatic behaviours in breast tumor cells

European journal of cancer supplements, 2008, Vol.6 (9), p.14-14

2008

Volltextzugriff (PDF)

The matrix PROLINE/Arginine-Rich End Leucin-Rich Repeat Protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity

Bone (New York, N.Y.), 2008, Vol.42 (Suppl. 1), p.S39-S40

2008

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)
Tagungsberichte
(4)

Sprache

Englisch
(42)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Orthopedics
(15)
Animals
(12)
Humans
(11)
Life Sciences & Biomedicine
(10)
Mice
(8)
Clinical Medicine
(6)
Endocrinology & Metabolism
(6)
Female
(6)
Klinisk Medicin
(6)
Medical And Health Sciences
(6)
Medicin Och Hälsovetenskap
(6)
Technology
(6)
Breast Cancer
(5)
Engineering
(5)
Hematology, Oncology And Palliative Medicine
(5)
Osteoclasts - Drug Effects
(5)
Bone Neoplasms - Secondary
(4)
Cell Line, Tumor
(4)
Cells, Cultured
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases

A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer’s Disease

An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6

c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation

Chondroadherin prevents bone loss and inhibits tumor growth in animal models of osteoporosis and cancer-induced bone disease

Lipocalin 2 is a novel mechanoresponding gene involved in osteoblast differentiation and osteoblast–osteoclast cross-talk

Pre-clinical employment of the heparin binding domain of PRELP in the treatment of bone loss diseases

Lipocalin2 is a new regulator of osteoblast functions in response to mechanical forces

978 Effects of 1D11 an Antibody Against Transforming Growth Factor Beta (TGF-b) on Incidence and Local Growth of Prostate Cancer Bone Metastases

976 Effects of Dual PI3K and mTOR Inhibition on Incidence and Local Growth of Prostate Cancer Bone Metastases

A new therapeutic approach to prevent oestrogen-withdrawal induced bone loss

Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans

The integrin binding domain of chondroadherin is a potential new target for drug development to treat bone metastases, affecting the players of the vicious cycle

Systemic and local determinants contribute to the bone phenotype in duchenne muscular dystrophy

Up-regulation of a set of genes in breast cancer bone metastases discloses predisposition to generate metastases also in visceral organs

The heparin binding domain of the bone protein proline/arginine-rich end leucine-rich repeat protein (PRELP) counteracts bone loss in ovariectomised (OVX) mice

Role of RAMP2 and BSP2 in the c-Src-regulated osteomimicry of breast cancer bone metastasis

Mechanisms underlying low bone density in muscular dystrophy

Mechanisms inducing low bone density in Duchenne Muscular Dystrophy

Proline/arginine‐rich end leucine‐rich repeat protein N‐terminus is a novel osteoclast antagonist that counteracts bone loss

Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs

368 The molecular switch NHERF1 induces tumour phenotypic changes associated with distinct metastatic organotropism in breast cancer via its PDZ domains

β‐Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice

NHERF1 programs invasive and metastatic behaviours in breast tumor cells

The matrix PROLINE/Arginine-Rich End Leucin-Rich Repeat Protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity

Suchergebnisse filtern